Skip to content

Published hearing · senate

S.Hrg.118-355

ORIGINS OF COVID-19: AN EXAMINATION OF AVAILABLE EVIDENCE

CHRG-118shrg56048

Publication

No. 355 · 2024-06-18 · GovInfo record 2024-10-15 · OTHERPART

No committee proceeding is explicitly associated with this publication.

Witness lines from the publication

  • Gregory D. Koblentz, Ph.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University
  • Robert F. Garry, Ph.D., Professor and Associate Dean, School of Medicine, Tulane University
  • Steven C. Quay, M.D., Ph.D., Chief Executive Officer, Atossa Therapeutics, Inc., Former Faculty Member, Stanford University School of Medicine
  • Richard H. Ebright, Ph.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University